Wendy is a biotechnology, pharma, and life science executive with more than 30 years of experience in the discovery and development of novel therapeutics. She was formerly the Senior Vice President at Genentech, where she actively built and led the small molecule drug discovery organization and co-led research. Under her leadership, more than 25 clinical candidates, in the areas of oncology, immunology, neurology, and anti-infectives, progressed into development. Additionally, Wendy led the BTK discovery program and is co-inventor of fenebrutinib. Prior to Genentech she held senior drug discovery leadership roles at J&J and Celera Genomics. She currently serves as an advisor to Google Ventures and is an associate editor of the Journal of Medicinal Chemistry. She received her Ph.D. in chemistry from Princeton University and was an American Cancer Society Postdoctoral Fellow at Sloan Kettering Cancer Center.
